Selank 10MG

Selank is a synthetic peptide derived from the somatostatin family, initially explored for its potential neuroprotective and anti-stress effects in preclinical research. This product is intended exclusively for academic and institutional research applications under strict regulatory oversight. Below is detailed information regarding its composition, relevance, and research context.

Research Context

Selank was first synthesized in Russia in the late 2000s and has since been subjected to extensive laboratory investigations. Its primary mechanism of action involves modulation of corticotropin-releasing factor (CRF) signaling pathways, which may contribute to stress response regulation, neuroprotection, and cognitive enhancement in animal models. While its therapeutic potential remains investigational, preclinical studies have provided foundational insights into its pharmacological properties.

Research Overview

Selank has been evaluated in rodent and non-human primate models to assess its effects on stress-related behaviors, neuroinflammation, and cognitive performance. Key studies have focused on its potential to counteract adverse effects of chronic stress, including hippocampal dysfunction and anxiety-like behaviors. Research also explores its neuroprotective role in conditions such as ischemia-reperfusion injury and neurodegenerative disease models.

Key Research Focus Areas

• Stress and Anxiety Regulation: Investigation of Selank’s ability to modulate stress-related neurotransmitter systems, including CRF, adrenocorticotropic hormone (ACTH), and glucocorticoid responses.
• Neuroprotection: Examination of its efficacy in preclinical models of cerebral ischemia, traumatic brain injury, and neurodegenerative pathologies (e.g., Alzheimer’s disease, Parkinson’s disease).
• Cognitive Enhancement: Assessing its effects on memory formation, learning capacity, and neuroplasticity under stress-induced cognitive impairment.
• Anti-Inflammatory Effects: Evaluation of its potential to reduce neuroinflammation via inhibition of pro-inflammatory cytokines (e.g., TNF-α, IL-1β) in experimental models.
• Gut-Brain Axis: Exploration of Selank’s role in modulating enteric nervous system activity and its implications for stress-related gut dysfunction.

Important Compliance and Safety Information

This peptide is intended solely for research purposes and must be handled with the utmost care. Users are responsible for ensuring compliance with all applicable local, regional, and national laws and regulations governing peptide synthesis, storage, and distribution. Research institutions conducting studies involving Selank must adhere to Institutional Review Board (IRB) or equivalent guidelines, particularly regarding animal welfare and biosafety protocols.

Due to its biological activity, Selank requires proper containment measures, including appropriate handling techniques to prevent exposure. It is not intended for human or animal consumption and should not be administered outside of a controlled research environment. Always consult with a qualified researcher or academic institution before use.

For research use only. Not for human or animal consumption.